ADVANCED MALIGNANT SOLID TUMOR
Clinical trials for ADVANCED MALIGNANT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug BNT314 enters first human safety tests
Disease control OngoingThis early study tests whether the experimental drug BNT314 is safe when given alone to people with advanced solid tumors that have not responded to other treatments. About 41 participants will receive increasing doses to find the highest dose with manageable side effects. The go…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE1 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 17, 2026 05:04 UTC
-
New antibody drug shows promise in Hard-to-Treat cancers
Disease control OngoingThis study tests an experimental drug called PRL3-zumab in 60 adults with advanced solid tumors that have not responded to standard treatments. The drug is given by IV every two weeks to see if it can slow tumor growth or shrink tumors. The main goals are to measure how long pati…
Matched conditions: ADVANCED MALIGNANT SOLID TUMOR
Phase: PHASE2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated May 15, 2026 11:56 UTC